BMJ Best Practice

参考文献

关键文献

James AH, Kouides PA, Abdul-Kadir R, et al. Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel. Am J Obstet Gynecol. 2009;201:12.e1-e8.

Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Investigation of intermenstrual and postcoital bleeding. July 2009. http://www.ranzcog.edu.au (last accessed 11 September 2017).

American Congress of Obstetricians and Gynecologists. ACOG technology assessment in obstetrics and gynecology no. 5: sonohysterography. Obstet Gynecol. 2008;112:1467-1469.

Oppenheimer L; Society of Obstetricians and Gynaecologists of Canada. Diagnosis and management of placenta previa. J Obstet Gynaecol Can. 2007;29:261-266.

Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64:1-137. [Erratum in: MMWR Recomm Rep. 2015;64:924.]

参考文章

1.  Oehler MK, Rees MC. Menorrhagia: an update. Acta Obstet Gynecol Scand. 2003;82:405-422.

2.  Farquhar CM, Steiner CA. Hysterectomy rates in the United States 1990-1997. Obstet Gynecol. 2002;99:229-234.

3.  Reid PC, Mukri F. Trends in number of hysterectomies performed in England for menorrhagia: examination of health episode statistics, 1989 to 2002-3. BMJ. 2005;330:938-939.

4.  Carlson KJ, Nichols DH, Schiff I. Indications for hysterectomy. N Engl J Med. 1993;328:856-860.

5.  Speroff L, Fritz M. Dysfunctional uterine bleeding. In: Speroff L, Fritz M, eds. Clinical gynecologic endocrinology and infertility. 7th edition. Philadelphia, PA: Lippincott Williams and Wilkins; 2005:547-571.

6.  James AH, Kouides PA, Abdul-Kadir R, et al. Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel. Am J Obstet Gynecol. 2009;201:12.e1-e8.

7.  Philipp CS, Faiz A, Dowling N, et al. Age and the prevalence of bleeding disorders in women with menorrhagia. Obstet Gynecol. 2005;105:61-66.

8.  Bouyer J, Coste J, Fernandez H, et al. Sites of ectopic pregnancy: a 10 year population-based study of 1800 cases. Hum Reprod. 2002;17:3224-3230.

9.  Ankum WM, Mol BW, Van Der Veen F, et al. Risk factors for ectopic pregnancy: a meta-analysis. Fertil Steril. 1996;65:1093-1099.

10.  Sivin I. Dose- and age-dependent ectopic pregnancy risks with intrauterine contraception. Obstet Gynecol. 1991;78:291-298.

11.  Peterson HB, Xia Z, Hughes JM, et al. The risk of ectopic pregnancy after tubal sterilization. US Collaborative Review of Sterilization Working Group. N Engl J Med. 1997;336:762-767.

12.  WHO Department of Reproductive Health and Research. Vaginal bleeding in early pregnancy: managing complications in pregnancy and childbirth, a guide for midwives and doctors. 2003. http://www.who.int/ (last accessed 11 September 2017).

13.  American College of Radiology. ACR appropriateness criteria: second and third trimester bleeding. 2013. http://www.acr.org/ (last accessed 11 September 2017).

14.  Sakornbut E, Leeman L, Fontaine P. Late pregnancy bleeding. Am Fam Physician. 2007;75:1199-1206.

15.  Magann EF, Cummings JE, Niederhauser A, et al. Antepartum bleeding of unknown origin in the second half of pregnancy: a review. Obstet Gynecol Surv. 2005;60:741-745.

16.  Kashanian M, Akbarian AR, Baradaran H, et al. Pregnancy outcome following a previous spontaneous abortion (miscarriage). Gynecol Obstet Invest. 2006;61:167-170.

17.  Sheiner E, Levy A, Katz M, et al. Pregnancy outcome following recurrent spontaneous abortions. Eur J Obstet Gynecol Reprod Biol. 2005;118:61-65.

18.  Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol. 2005;192:1458-1461.

19.  Zhou W, Nielsen GL, Larsen H, et al. Induced abortion and placenta complications in the subsequent pregnancy. Acta Obstet Gynecol Scand. 2001;80:1115-1120.

20.  Conde-Agudelo A, Rosas-Bermudez A, Kafury-Goeta AC. Effects of birth spacing on maternal health: a systematic review. Am J Obstet Gynecol. 2007;196:297-308.

21.  American Congress of Obstetricians and Gynecologists. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists: use of botanicals for management of menopausal symptoms. Obstet Gynecol. 2001;97(suppl):1-11.

22.  American Congress of Obstetricians and Gynecologists. ACOG practice bulletin no. 94: medical management of ectopic pregnancy. Obstet Gynecol. 2008;111:1479-1485.

23.  Lozeau AM, Potter B. Diagnosis and management of ectopic pregnancy. Am Fam Physician. 2005;72:1707.

24.  Isoardi K. Review article: the use of pelvic examination within the emergency department in the assessment of early pregnancy bleeding. Emerg Med Australas. 2009;21:440-448.

25.  Stovall TG, Ling FW, Morgan PL. A prospective, randomized comparison of the Pipelle endometrial sampling device with the Novak curette. Am J Obstet Gynecol. 1991;165:1287-1290.

26.  Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Investigation of intermenstrual and postcoital bleeding. July 2009. http://www.ranzcog.edu.au (last accessed 11 September 2017).

27.  McRae A, Murray H, Edmonds M, et al. Diagnostic accuracy and clinical utility of emergency department targeted ultrasonography in the evaluation of first-trimester pelvic pain and bleeding: a systematic review. CJEM. 2009;11:355-364.

28.  American Congress of Obstetricians and Gynecologists. ACOG technology assessment in obstetrics and gynecology no. 5: sonohysterography. Obstet Gynecol. 2008;112:1467-1469.

29.  American College of Radiology. ACR appropriateness criteria: abnormal vaginal bleeding. 2014. http://www.acr.org/ (last accessed 11 September 2017).

30.  Yudin MH, Hillier SL, Wiesenfeld HC, et al. Vaginal polymorphonuclear leukocytes and bacterial vaginosis as markers for histologic endometritis among women without symptoms of pelvic inflammatory disease. Am J Obstet Gynecol. 2003;188:318-323.

31.  van DH, de-Kroon CD, Jacobi CE, et al. Diagnostic hysteroscopy in abnormal uterine bleeding: a systematic review and meta-analysis. BJOG. 2007;114:664-675.

32.  Daniilidis A, Pantelis A, Dinas K, et al. Indications of diagnostic hysteroscopy, a brief review of the literature. Gynecological Surgery. 2012;9:23-28.

33.  Royal College of Obstetricians and Gynaecologists. Best practice in outpatient hysteroscopy. March 2011. http://www.rcog.org.uk (last accessed 11 September 2017).

34.  Hoelzer D, Gökbuget N, Ottmann O, et al. Acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program. 2002:162-192.

35.  Jabbour EJ, Faderl S, Kantarjian HM. Adult acute lymphoblastic leukemia. Mayo Clin Proc. 2005;80:1517-1527.

36.  Trey C, Davidson CS. The management of fulminant hepatic failure. Prog Liver Dis. 1970;3:282-298.

37.  Gimson AE, O'Grady J, Ede RJ, et al. Late onset hepatic failure: clinical, serological and histological features. Hepatology. 1986;6:288-294.

38.  Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis. 1986;6:97-106.

39.  O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet. 1993;342:273-275.

40.  Peake I, Goodeve A. Type 1 von Willebrand disease. J Thromb Haemost. 2007;5(suppl 1):7-11.

41.  Blomback M, Konkle BA, Manco-Johnson MJ, et al. Preanalytical conditions that affect coagulation testing, including hormonal status and therapy. J Thromb Haemost. 2007;5:855-858.

42.  Emery CL, Morway LF, Chung-Park M, et al. The Kleihauer-Betke test. Clinical utility, indication, and correlation in patients with placental abruption and cocaine use. Arch Pathol Lab Med. 1995;119:1032-1037.

43.  Dhanraj D, Lambers D. The incidences of positive Kleihauer-Betke test in low-risk pregnancies and maternal trauma patients. Am J Obstet Gynecol. 2004;190:1461-1463.

44.  Kikutani M, Ishihara K, Araki T. Value of ultrasonography in the diagnosis of placental abruption. J Nippon Med Sch. 2003;70:227-233.

45.  Yeo L, Ananth C, Vintzileos A. Placental abruption. In: Sciarra J, ed. Gynecology and obstetrics. Hagerstown, MD: Lippincott, Williams & Wilkins; 2004.

46.  Glantz C, Purnell L. Clinical utility of sonography in the diagnosis and treatment of placental abruption. J Ultrasound Med. 2002;21:837-840.

47.  Oppenheimer L; Society of Obstetricians and Gynaecologists of Canada. Diagnosis and management of placenta previa. J Obstet Gynaecol Can. 2007;29:261-266.

48.  Royal College of Obstetricians and Gynaecologists. Placenta praevia, placenta praevia accreta and vasa praevia: diagnosis and management. January 2011. http://www.rcog.org.uk/guidelines (last accessed 11 September 2017).

49.  Ultrasonography in pregnancy. Washington, DC: American Congress of Obstetricians and Gynecologists; 2004. ACOG Practice Bulletin, No. 58.

50.  Oppenheimer L, Holmes P, Simpson N, et al. Diagnosis of low-lying placenta: can migration in the third trimester predict outcome? Ultrasound Obstet Gynecol. 2001;18:100-102.

51.  Predanic M, Perni SC, Baergen RN, et al. A sonographic assessment of different patterns of placenta previa "migration" in the third trimester of pregnancy. J Ultrasound Med. 2005;24:773-780.

52.  Olive EC, Roberts CL, Nassar N, et al. Test characteristics of placental location screening by transabdominal ultrasound at 18-20 weeks. Ultrasound Obstet Gynecol. 2006;28:944-949.

53.  Dashe JS, McIntire DD, Ramus RM, et al. Persistence of placenta previa according to gestational age at ultrasound detection. Obstet Gynecol. 2002;99:692-697.

54.  Abramowicz JS, Sheiner E. In utero imaging of the placenta: importance for diseases of pregnancy. Placenta. 2007;28(suppl A):S14-S22.

55.  Bhide A, Prefumo F, Moore J, et al. Placental edge to internal os distance in the late third trimester and mode of delivery in placenta praevia. BJOG. 2003;110:860-864.

56.  Comstock CH, Love JJ, Bronsteen RA, et al. Sonographic detection of placenta accreta in the second and third trimesters of pregnancy. Am J Obstet Gynecol. 2004;190:1135-1140.

57.  Adeyomoye AA, Ola ER, Arogundade RA, et al. Comparison of the accuracy of trans-abdominal sonography (TAS) and transperineal sonography (TPS) in the diagnosis of placenta praevia. Niger Postgrad Med J. 2006;13:21-25.

58.  Crossman SH. The challenge of pelvic inflammatory disease. Am Fam Physician. 2006;73:859-864.

59.  Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64:1-137. [Erratum in: MMWR Recomm Rep. 2015;64:924.]

60.  Marrazzo JM, Martin DH. Management of women with cervicitis. Clin Infect Dis. 2007;44(suppl 3):S102-S110.

61.  Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991;29:297-301.

62.  Day Baird D, Dunson DB, Hill MC, et al. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188:100-107.

63.  ACOG Committee on Gynecologic Practice. Committee opinion: number 263, December 2001: von Willebrand's disease in gynecologic practice. Obstet Gynecol. 2001;98:1185-1186.

64.  Howlader N, Noone AM, Krapcho M, et al, eds. SEER cancer statistics review, 1975-2008. 2011. http://seer.cancer.gov (last accessed 11 September 2017).

65.  Bazot M, Thomassin I, Hourani R, et al. Diagnostic accuracy of transvaginal sonography for deep pelvic endometriosis. Ultrasound Obstet Gynecol. 2004;24:180-185.

66.  Chapron C, Vieira M, Chopin N, et al. Accuracy of rectal endoscopic ultrasonography and magnetic resonance imaging in the diagnosis of rectal involvement for patients presenting with deeply infiltrating endometriosis. Ultrasound Obstet Gynecol. 2004;24:175-179.

67.  Bazot M, Darai E, Hourani R, et al. Deep pelvic endometriosis: MR imaging for diagnosis and prediction of extension of disease. Radiology. 2004;232:379-389.

使用此内容应接受我们的免责声明